Global Point-of-care Testing (POCT) for Chronic Disease Market Research Report 2025(Status and Outlook)
Description
Report Overview
Point-of-care testing (POCT) for chronic diseases refers to diagnostic tests performed near or at the site of patient care, enabling rapid results that facilitate immediate clinical decision-making. These tests are designed for conditions such as diabetes, cardiovascular diseases, chronic kidney disease, and respiratory disorders, providing real-time monitoring of biomarkers like blood glucose, cholesterol, HbA1c, creatinine, and inflammatory markers. POCT devices are portable, user-friendly, and often integrate with digital health platforms, enhancing accessibility in primary care, home settings, and low-resource environments. By reducing turnaround times and eliminating lab dependencies, POCT improves patient compliance, early intervention, and personalized disease management, making it a critical tool in chronic care.
The global POCT market for chronic diseases is experiencing robust growth, driven by the rising prevalence of chronic conditions, aging populations, and the demand for decentralized healthcare solutions. Technological advancements, such as miniaturization, biosensors, and connectivity with electronic health records, are expanding the capabilities of POCT devices. Key players include Abbott, Roche, Siemens Healthineers, and Danaher, which dominate through innovation in multiplex testing and AI-driven analytics. However, challenges like regulatory hurdles, reimbursement limitations, and accuracy concerns in high-complexity tests restrain market expansion. Emerging economies present significant opportunities due to increasing healthcare infrastructure investments and the need for cost-effective diagnostic solutions. The market is projected to grow at a CAGR of 7-9% over the next five years, fueled by the shift toward preventive care and remote patient monitoring.
Diabetes management remains the largest application segment, with glucose monitoring devices leading adoption. Cardiovascular and renal POCT are also gaining traction, supported by biomarker validation and telehealth integration. Home-based testing is rising, particularly post-pandemic, as patients seek convenience and reduced hospital visits. Regulatory bodies like the FDA and EMA are streamlining approvals for novel POCT technologies, while reimbursement policies in developed markets encourage adoption. Competitive strategies focus on partnerships with digital health providers and expansion into underserved regions. Despite cost sensitivity in low-income settings, the long-term benefits of POCT in reducing hospitalizations and improving outcomes position it as a transformative force in chronic disease management.
The global Point-of-care Testing (POCT) for Chronic Disease market size was estimated at USD 2392.87 million in 2024, exhibiting a CAGR of 8.25% during the forecast period.
This report provides a deep insight into the global Point-of-care Testing (POCT) for Chronic Disease market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Point-of-care Testing (POCT) for Chronic Disease Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Point-of-care Testing (POCT) for Chronic Disease market in any manner.
Global Point-of-care Testing (POCT) for Chronic Disease Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott
BioMerieux
Siemens Healthineers
Roche
Danaher
Sinocare Inc
Assure Tech (Hangzhou) Co.,Ltd.
Bio-Rad Laboratories
Guangzhou Wondfo Biotech Co.,Ltd.
Wuhan Easy Diagnosis Biomedicine Co.,ltd.
Market Segmentation (by Type)
Based on Immunochromatography
Based on Chemiluminescence Technology
Based on Biosensor
Others
Market Segmentation (by Application)
Hospital
lndependent Testing Organization
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Point-of-care Testing (POCT) for Chronic Disease Market
Overview of the regional outlook of the Point-of-care Testing (POCT) for Chronic Disease Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Point-of-care Testing (POCT) for Chronic Disease Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Point-of-care Testing (POCT) for Chronic Disease, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Point-of-care testing (POCT) for chronic diseases refers to diagnostic tests performed near or at the site of patient care, enabling rapid results that facilitate immediate clinical decision-making. These tests are designed for conditions such as diabetes, cardiovascular diseases, chronic kidney disease, and respiratory disorders, providing real-time monitoring of biomarkers like blood glucose, cholesterol, HbA1c, creatinine, and inflammatory markers. POCT devices are portable, user-friendly, and often integrate with digital health platforms, enhancing accessibility in primary care, home settings, and low-resource environments. By reducing turnaround times and eliminating lab dependencies, POCT improves patient compliance, early intervention, and personalized disease management, making it a critical tool in chronic care.
The global POCT market for chronic diseases is experiencing robust growth, driven by the rising prevalence of chronic conditions, aging populations, and the demand for decentralized healthcare solutions. Technological advancements, such as miniaturization, biosensors, and connectivity with electronic health records, are expanding the capabilities of POCT devices. Key players include Abbott, Roche, Siemens Healthineers, and Danaher, which dominate through innovation in multiplex testing and AI-driven analytics. However, challenges like regulatory hurdles, reimbursement limitations, and accuracy concerns in high-complexity tests restrain market expansion. Emerging economies present significant opportunities due to increasing healthcare infrastructure investments and the need for cost-effective diagnostic solutions. The market is projected to grow at a CAGR of 7-9% over the next five years, fueled by the shift toward preventive care and remote patient monitoring.
Diabetes management remains the largest application segment, with glucose monitoring devices leading adoption. Cardiovascular and renal POCT are also gaining traction, supported by biomarker validation and telehealth integration. Home-based testing is rising, particularly post-pandemic, as patients seek convenience and reduced hospital visits. Regulatory bodies like the FDA and EMA are streamlining approvals for novel POCT technologies, while reimbursement policies in developed markets encourage adoption. Competitive strategies focus on partnerships with digital health providers and expansion into underserved regions. Despite cost sensitivity in low-income settings, the long-term benefits of POCT in reducing hospitalizations and improving outcomes position it as a transformative force in chronic disease management.
The global Point-of-care Testing (POCT) for Chronic Disease market size was estimated at USD 2392.87 million in 2024, exhibiting a CAGR of 8.25% during the forecast period.
This report provides a deep insight into the global Point-of-care Testing (POCT) for Chronic Disease market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Point-of-care Testing (POCT) for Chronic Disease Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Point-of-care Testing (POCT) for Chronic Disease market in any manner.
Global Point-of-care Testing (POCT) for Chronic Disease Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott
BioMerieux
Siemens Healthineers
Roche
Danaher
Sinocare Inc
Assure Tech (Hangzhou) Co.,Ltd.
Bio-Rad Laboratories
Guangzhou Wondfo Biotech Co.,Ltd.
Wuhan Easy Diagnosis Biomedicine Co.,ltd.
Market Segmentation (by Type)
Based on Immunochromatography
Based on Chemiluminescence Technology
Based on Biosensor
Others
Market Segmentation (by Application)
Hospital
lndependent Testing Organization
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Point-of-care Testing (POCT) for Chronic Disease Market
Overview of the regional outlook of the Point-of-care Testing (POCT) for Chronic Disease Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Point-of-care Testing (POCT) for Chronic Disease Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Point-of-care Testing (POCT) for Chronic Disease, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
151 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Point-of-care Testing (POCT) for Chronic Disease
- 1.2 Key Market Segments
- 1.2.1 Point-of-care Testing (POCT) for Chronic Disease Segment by Type
- 1.2.2 Point-of-care Testing (POCT) for Chronic Disease Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Point-of-care Testing (POCT) for Chronic Disease Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Point-of-care Testing (POCT) for Chronic Disease Market Size (M USD) Estimates and Forecasts (2020-2033)
- 2.1.2 Global Point-of-care Testing (POCT) for Chronic Disease Sales Estimates and Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Point-of-care Testing (POCT) for Chronic Disease Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Point-of-care Testing (POCT) for Chronic Disease Product Life Cycle
- 3.3 Global Point-of-care Testing (POCT) for Chronic Disease Sales by Manufacturers (2020-2025)
- 3.4 Global Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Point-of-care Testing (POCT) for Chronic Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 Point-of-care Testing (POCT) for Chronic Disease Market Competitive Situation and Trends
- 3.8.1 Point-of-care Testing (POCT) for Chronic Disease Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Point-of-care Testing (POCT) for Chronic Disease Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Point-of-care Testing (POCT) for Chronic Disease Industry Chain Analysis
- 4.1 Point-of-care Testing (POCT) for Chronic Disease Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Point-of-care Testing (POCT) for Chronic Disease Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Point-of-care Testing (POCT) for Chronic Disease Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Point-of-care Testing (POCT) for Chronic Disease Market
- 5.7 ESG Ratings of Leading Companies
- 6 Point-of-care Testing (POCT) for Chronic Disease Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Type (2020-2025)
- 6.3 Global Point-of-care Testing (POCT) for Chronic Disease Market Size Market Share by Type (2020-2025)
- 6.4 Global Point-of-care Testing (POCT) for Chronic Disease Price by Type (2020-2025)
- 7 Point-of-care Testing (POCT) for Chronic Disease Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Point-of-care Testing (POCT) for Chronic Disease Market Sales by Application (2020-2025)
- 7.3 Global Point-of-care Testing (POCT) for Chronic Disease Market Size (M USD) by Application (2020-2025)
- 7.4 Global Point-of-care Testing (POCT) for Chronic Disease Sales Growth Rate by Application (2020-2025)
- 8 Point-of-care Testing (POCT) for Chronic Disease Market Sales by Region
- 8.1 Global Point-of-care Testing (POCT) for Chronic Disease Sales by Region
- 8.1.1 Global Point-of-care Testing (POCT) for Chronic Disease Sales by Region
- 8.1.2 Global Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Region
- 8.2 Global Point-of-care Testing (POCT) for Chronic Disease Market Size by Region
- 8.2.1 Global Point-of-care Testing (POCT) for Chronic Disease Market Size by Region
- 8.2.2 Global Point-of-care Testing (POCT) for Chronic Disease Market Size Market Share by Region
- 8.3 North America
- 8.3.1 North America Point-of-care Testing (POCT) for Chronic Disease Sales by Country
- 8.3.2 North America Point-of-care Testing (POCT) for Chronic Disease Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Point-of-care Testing (POCT) for Chronic Disease Sales by Country
- 8.4.2 Europe Point-of-care Testing (POCT) for Chronic Disease Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Point-of-care Testing (POCT) for Chronic Disease Sales by Region
- 8.5.2 Asia Pacific Point-of-care Testing (POCT) for Chronic Disease Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Point-of-care Testing (POCT) for Chronic Disease Sales by Country
- 8.6.2 South America Point-of-care Testing (POCT) for Chronic Disease Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Point-of-care Testing (POCT) for Chronic Disease Sales by Region
- 8.7.2 Middle East and Africa Point-of-care Testing (POCT) for Chronic Disease Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Point-of-care Testing (POCT) for Chronic Disease Market Production by Region
- 9.1 Global Production of Point-of-care Testing (POCT) for Chronic Disease by Region(2020-2025)
- 9.2 Global Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Region (2020-2025)
- 9.3 Global Point-of-care Testing (POCT) for Chronic Disease Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Point-of-care Testing (POCT) for Chronic Disease Production
- 9.4.1 North America Point-of-care Testing (POCT) for Chronic Disease Production Growth Rate (2020-2025)
- 9.4.2 North America Point-of-care Testing (POCT) for Chronic Disease Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Point-of-care Testing (POCT) for Chronic Disease Production
- 9.5.1 Europe Point-of-care Testing (POCT) for Chronic Disease Production Growth Rate (2020-2025)
- 9.5.2 Europe Point-of-care Testing (POCT) for Chronic Disease Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Point-of-care Testing (POCT) for Chronic Disease Production (2020-2025)
- 9.6.1 Japan Point-of-care Testing (POCT) for Chronic Disease Production Growth Rate (2020-2025)
- 9.6.2 Japan Point-of-care Testing (POCT) for Chronic Disease Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Point-of-care Testing (POCT) for Chronic Disease Production (2020-2025)
- 9.7.1 China Point-of-care Testing (POCT) for Chronic Disease Production Growth Rate (2020-2025)
- 9.7.2 China Point-of-care Testing (POCT) for Chronic Disease Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Abbott
- 10.1.1 Abbott Basic Information
- 10.1.2 Abbott Point-of-care Testing (POCT) for Chronic Disease Product Overview
- 10.1.3 Abbott Point-of-care Testing (POCT) for Chronic Disease Product Market Performance
- 10.1.4 Abbott Business Overview
- 10.1.5 Abbott SWOT Analysis
- 10.1.6 Abbott Recent Developments
- 10.2 BioMerieux
- 10.2.1 BioMerieux Basic Information
- 10.2.2 BioMerieux Point-of-care Testing (POCT) for Chronic Disease Product Overview
- 10.2.3 BioMerieux Point-of-care Testing (POCT) for Chronic Disease Product Market Performance
- 10.2.4 BioMerieux Business Overview
- 10.2.5 BioMerieux SWOT Analysis
- 10.2.6 BioMerieux Recent Developments
- 10.3 Siemens Healthineers
- 10.3.1 Siemens Healthineers Basic Information
- 10.3.2 Siemens Healthineers Point-of-care Testing (POCT) for Chronic Disease Product Overview
- 10.3.3 Siemens Healthineers Point-of-care Testing (POCT) for Chronic Disease Product Market Performance
- 10.3.4 Siemens Healthineers Business Overview
- 10.3.5 Siemens Healthineers SWOT Analysis
- 10.3.6 Siemens Healthineers Recent Developments
- 10.4 Roche
- 10.4.1 Roche Basic Information
- 10.4.2 Roche Point-of-care Testing (POCT) for Chronic Disease Product Overview
- 10.4.3 Roche Point-of-care Testing (POCT) for Chronic Disease Product Market Performance
- 10.4.4 Roche Business Overview
- 10.4.5 Roche Recent Developments
- 10.5 Danaher
- 10.5.1 Danaher Basic Information
- 10.5.2 Danaher Point-of-care Testing (POCT) for Chronic Disease Product Overview
- 10.5.3 Danaher Point-of-care Testing (POCT) for Chronic Disease Product Market Performance
- 10.5.4 Danaher Business Overview
- 10.5.5 Danaher Recent Developments
- 10.6 Sinocare Inc
- 10.6.1 Sinocare Inc Basic Information
- 10.6.2 Sinocare Inc Point-of-care Testing (POCT) for Chronic Disease Product Overview
- 10.6.3 Sinocare Inc Point-of-care Testing (POCT) for Chronic Disease Product Market Performance
- 10.6.4 Sinocare Inc Business Overview
- 10.6.5 Sinocare Inc Recent Developments
- 10.7 Assure Tech (Hangzhou) Co.,Ltd.
- 10.7.1 Assure Tech (Hangzhou) Co.,Ltd. Basic Information
- 10.7.2 Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Product Overview
- 10.7.3 Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Product Market Performance
- 10.7.4 Assure Tech (Hangzhou) Co.,Ltd. Business Overview
- 10.7.5 Assure Tech (Hangzhou) Co.,Ltd. Recent Developments
- 10.8 Bio-Rad Laboratories
- 10.8.1 Bio-Rad Laboratories Basic Information
- 10.8.2 Bio-Rad Laboratories Point-of-care Testing (POCT) for Chronic Disease Product Overview
- 10.8.3 Bio-Rad Laboratories Point-of-care Testing (POCT) for Chronic Disease Product Market Performance
- 10.8.4 Bio-Rad Laboratories Business Overview
- 10.8.5 Bio-Rad Laboratories Recent Developments
- 10.9 Guangzhou Wondfo Biotech Co.,Ltd.
- 10.9.1 Guangzhou Wondfo Biotech Co.,Ltd. Basic Information
- 10.9.2 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Product Overview
- 10.9.3 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Product Market Performance
- 10.9.4 Guangzhou Wondfo Biotech Co.,Ltd. Business Overview
- 10.9.5 Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments
- 10.10 Wuhan Easy Diagnosis Biomedicine Co.,ltd.
- 10.10.1 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Basic Information
- 10.10.2 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Chronic Disease Product Overview
- 10.10.3 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Chronic Disease Product Market Performance
- 10.10.4 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Business Overview
- 10.10.5 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Recent Developments
- 11 Point-of-care Testing (POCT) for Chronic Disease Market Forecast by Region
- 11.1 Global Point-of-care Testing (POCT) for Chronic Disease Market Size Forecast
- 11.2 Global Point-of-care Testing (POCT) for Chronic Disease Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Point-of-care Testing (POCT) for Chronic Disease Market Size Forecast by Country
- 11.2.3 Asia Pacific Point-of-care Testing (POCT) for Chronic Disease Market Size Forecast by Region
- 11.2.4 South America Point-of-care Testing (POCT) for Chronic Disease Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Point-of-care Testing (POCT) for Chronic Disease by Country
- 12 Forecast Market by Type and by Application (2026-2033)
- 12.1 Global Point-of-care Testing (POCT) for Chronic Disease Market Forecast by Type (2026-2033)
- 12.1.1 Global Forecasted Sales of Point-of-care Testing (POCT) for Chronic Disease by Type (2026-2033)
- 12.1.2 Global Point-of-care Testing (POCT) for Chronic Disease Market Size Forecast by Type (2026-2033)
- 12.1.3 Global Forecasted Price of Point-of-care Testing (POCT) for Chronic Disease by Type (2026-2033)
- 12.2 Global Point-of-care Testing (POCT) for Chronic Disease Market Forecast by Application (2026-2033)
- 12.2.1 Global Point-of-care Testing (POCT) for Chronic Disease Sales (K Units) Forecast by Application
- 12.2.2 Global Point-of-care Testing (POCT) for Chronic Disease Market Size (M USD) Forecast by Application (2026-2033)
- 13 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
